» Articles » PMID: 27713030

Role of the JAK/STAT Signaling Pathway in Regulation of Innate Immunity in Neuroinflammatory Diseases

Overview
Journal Clin Immunol
Date 2016 Oct 8
PMID 27713030
Citations 101
Authors
Affiliations
Soon will be listed here.
Abstract

The Janus Kinase/Signal Transducers and Activators of Transcription (JAK/STAT) signaling pathway is utilized by numerous cytokines and interferons, and is essential for the development and function of both innate and adaptive immunity. Aberrant activation of the JAK/STAT pathway is evident in neuroinflammatory diseases such as Multiple Sclerosis and Parkinson's Disease. Innate immunity is the front line defender of the immune system and is composed of various cell types, including microglia, macrophages and neutrophils. Innate immune responses have both pathogenic and protective roles in neuroinflammation, depending on disease context and the microenvironment in the central nervous system. In this review, we discuss the role of innate immunity in the pathogenesis of neuroinflammatory diseases, how the JAK/STAT signaling pathway regulates the innate immune response, and finally, the potential for ameliorating neuroinflammation by utilization of JAK/STAT inhibitors.

Citing Articles

Posterior cingulate cortex microRNA dysregulation differentiates cognitive resilience, mild cognitive impairment, and Alzheimer's disease.

Counts S, Beck J, Maloney B, Malek-Ahmadi M, Ginsberg S, Mufson E Alzheimers Dement. 2025; 21(2):e70019.

PMID: 40008917 PMC: 11863362. DOI: 10.1002/alz.70019.


Investigating associations between JAK inhibition and venous thromboembolism by systematic mining of large-scale datasets.

Haysen S, Nielsen A, Qvist P, Kragstrup T Inflammopharmacology. 2025; .

PMID: 39994070 DOI: 10.1007/s10787-025-01677-2.


Transcriptomics-based investigation of resistance differences to swine fever between large white pigs and min pigs.

Li J, Ren D, Meng X, He Y, Wang L, Sheng X Virus Res. 2025; 353:199536.

PMID: 39875015 PMC: 11841072. DOI: 10.1016/j.virusres.2025.199536.


Molecular Mechanisms Underlying Neuroinflammation Intervention with Medicinal Plants: A Critical and Narrative Review of the Current Literature.

Barbalho S, Leme Boaro B, da Silva Camarinha Oliveira J, Patocka J, Lamas C, Tanaka M Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861194 PMC: 11768729. DOI: 10.3390/ph18010133.


Exploring the clinical potential of circulating LncRNAs in breast cancer: insights into primary signaling pathways and therapeutic interventions.

Al-Noshokaty T, Abdelhamid R, Reda T, Alaaeldien A, Abdellatif N, Mansour A Funct Integr Genomics. 2024; 24(6):209.

PMID: 39508907 DOI: 10.1007/s10142-024-01476-y.


References
1.
Mantovani A, Sica A, Locati M . Macrophage polarization comes of age. Immunity. 2005; 23(4):344-6. DOI: 10.1016/j.immuni.2005.10.001. View

2.
Liu Y, Holdbrooks A, De Sarno P, Rowse A, Yanagisawa L, McFarland B . Therapeutic efficacy of suppressing the Jak/STAT pathway in multiple models of experimental autoimmune encephalomyelitis. J Immunol. 2013; 192(1):59-72. PMC: 3934829. DOI: 10.4049/jimmunol.1301513. View

3.
Hamilton J . Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol. 2008; 8(7):533-44. DOI: 10.1038/nri2356. View

4.
Polymeropoulos M, Lavedan C, Leroy E, Ide S, Dehejia A, Dutra A . Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997; 276(5321):2045-7. DOI: 10.1126/science.276.5321.2045. View

5.
Vogel D, Vereyken E, Glim J, Heijnen P, Moeton M, van der Valk P . Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. J Neuroinflammation. 2013; 10:35. PMC: 3610294. DOI: 10.1186/1742-2094-10-35. View